These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Peptic ulcer in cirrhotic patients: a short- and long-term study with antisecretory drugs. Di Mario F, Gottardello L, Germanà B, Dotto P, Grassi SA, Vianello F, Battaglia G, Leandro G, Burra P, Salvagnini M. Ital J Gastroenterol; 1992; 24(3):122-5. PubMed ID: 1348650 [Abstract] [Full Text] [Related]
3. Effect of Helicobacter pylori eradication and antisecretory maintenance therapy on peptic ulcer recurrence in cirrhotic patients: a prospective, cohort 2-year follow-up study. Tzathas C, Triantafyllou K, Mallas E, Triantafyllou G, Ladas SD. J Clin Gastroenterol; 2008 Jul; 42(6):744-9. PubMed ID: 18277886 [Abstract] [Full Text] [Related]
4. Maintenance treatment is not necessary after Helicobacter pylori eradication and healing of bleeding peptic ulcer: a 5-year prospective, randomized, controlled study. Liu CC, Lee CL, Chan CC, Tu TC, Liao CC, Wu CH, Chen TK. Arch Intern Med; 2003 Sep 22; 163(17):2020-4. PubMed ID: 14504114 [Abstract] [Full Text] [Related]
5. Omeprazole in acute and long-term treatment of Asian patients with peptic ulcer refractory to H2-antagonists. Chelvam P, Wong EC. J Gastroenterol Hepatol; 1989 Sep 22; 4 Suppl 2():75-81. PubMed ID: 2577478 [Abstract] [Full Text] [Related]
9. [H2 receptor antagonists in the therapy of peptic ulcer disease]. Dammann HG, Dau B, Dreyer M, Müller P, Simon B. Z Gastroenterol; 1987 Aug 22; 25 Suppl 3():136-45. PubMed ID: 2889298 [Abstract] [Full Text] [Related]
10. [Mechanism of action and therapeutic effectiveness of histamine H2 receptor blockaders in peptic ulcer]. Glubochenko VG, Shcherbak VV. Vrach Delo; 1985 Feb 22; (2):13-5. PubMed ID: 2859701 [No Abstract] [Full Text] [Related]
11. [Sulglycotide combined with H2-antagonists in the prevention of duodenal ulcer recurrence. Multicenter study]. Ciaco A, Papi C, Capurso L. Minerva Gastroenterol Dietol; 1992 Feb 22; 38(3):153-9. PubMed ID: 1363719 [Abstract] [Full Text] [Related]
12. [Absence of bleeding recurrence of peptic ulcer after long term follow-up of successful eradication of Helicobacter pylori]. Amendola M, Farias R, Katz J, Luna P, Ianella M, Musi A, Boerr L, Valero J, Kogan Z, Corti R. Acta Gastroenterol Latinoam; 1999 Feb 22; 29(2):47-50. PubMed ID: 10491714 [Abstract] [Full Text] [Related]
14. A randomized controlled trial of test-and-treat strategy for Helicobacter pylori: clinical outcomes and health care costs in a managed care population receiving long-term acid suppression therapy for physician-diagnosed peptic ulcer disease. Allison JE, Hurley LB, Hiatt RA, Levin TR, Ackerson LM, Lieu TA. Arch Intern Med; 2003 May 26; 163(10):1165-71. PubMed ID: 12767952 [Abstract] [Full Text] [Related]
16. Study of outcome after targeted intervention for peptic ulcer resistant to acid suppression therapy. Lanas A, Remacha B, Sáinz R, Hirschowitz BI. Am J Gastroenterol; 2000 Feb 26; 95(2):513-9. PubMed ID: 10685760 [Abstract] [Full Text] [Related]